Adenocarcinoma (3) survie (2) Diagnosis (2) Methods (2) Epidermal growth factor (2) Survival (2) Patients (2) Metastasis (2) Impact (2) Immunohistochemistry (2) Evaluation (2) Diagnosis (2) Cancer (2) Brain (2) Tax assessment (2) Addition (2) Methods (2) Patients (2) cerveau (2) temps (durée) (1) stratification (1) norme (1) région (1) Asie (1) gestion (1) perte (1) in situ (1) innovation (1) hybridation (1) soins de santé (1)